Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microneedles Detect Real-Time Chemical Changes in the Body

By LabMedica International staff writers
Posted on 19 Jan 2012
A new technology uses microneedles to allow doctors to detect real-time chemical changes in the body--and to do so continuously for an extended period of time.

Microneedles are very small needles in which at least one dimension--such as length--is less than one millimeter. More...
The hollow channels within microneedles are loaded with electrochemical sensors that can be used to detect specific molecules or pH levels.
Existing technology relies on taking samples and testing them, whereas this approach allows continuous monitoring, explained Prof. Narayan of NC State's College of Engineering (Raleigh, NC, USA) and the University of North Carolina at Chapel Hill (NC, USA). "For example, it could monitor glucose levels in a diabetic patient," he said.

The scientists developed a proof-of-concept sensor array incorporating three types of sensors, which could measure pH, glucose, and lactate. However, Prof. Narayan says the array could be modified to monitor a wide variety of chemicals.

"The idea is that customized microneedle sensor arrays could be developed and incorporated into wearable devices, such as something like a wristwatch, to help answer specific medical or research questions," added Prof. Narayan. "It's also worth pointing out that microneedles are not painful."

The technology was developed by scientists from North Carolina State University (Raleigh, NC, USA), Sandia National Laboratories (Albuquerque, NM, USA), and the University of California, San Diego (CA, USA).

The microneedles were described online in the November 2011 edition of the journal Talanta.

Related Links:
NC State's College of Engineering
University of North Carolina at Chapel Hill
Sandia National Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.